Related Experiment Video
Updated: Jul 2, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
Knockdown of DDX46 Inhibits the Invasion and Tumorigenesis in Osteosarcoma Cells
Abstract:
DDX46, a member of the DEAD-box (DDX) helicase family, is involved in the development of several tumors. However, the exact role of DDX46 in osteosarcoma and the underlying mechanisms in tumorigenesis remain poorly understood. Thus, in the present study, we explored the role of DDX46 in osteosarcoma and the underlying mechanisms. Our results demonstrated that the expression levels of DDX46 in both mRNA and protein were greatly elevated in human osteosarcoma tissues and cell lines. Knockdown of DDX46 obviously inhibited osteosarcoma cell proliferation and tumor growth in vivo. In addition, knockdown of DDX46 also significantly suppressed migration and invasion in osteosarcoma cells. Furthermore, knockdown of DDX46 substantially downregulated the phosphorylation levels of PI3K and Akt in SaOS2 cells. In summary, the present results have revealed that DDX46 plays an important role in osteosarcoma growth and metastasis. Knockdown of DDX46 inhibited osteosarcoma cell proliferation, migration, and invasion in vitro and tumor growth in vivo. Therefore, DDX46 may be a potential therapeutic target for the treatment of osteosarcoma.
Insights
The DEAD-box helicase DDX46 is highly expressed in osteosarcoma, promoting tumor growth and metastasis. Inhibiting DDX46 suppressed osteosarcoma progression and may offer a new therapeutic strategy.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- The DEAD-box helicase family plays a role in various cancers.
- The specific function of DDX46 in osteosarcoma tumorigenesis is not well understood.
Purpose of the Study:
- To investigate the role of DDX46 in osteosarcoma development and its underlying mechanisms.
- To evaluate DDX46 as a potential therapeutic target for osteosarcoma.
Main Methods:
- Assessed DDX46 expression in osteosarcoma tissues and cell lines.
- Performed in vitro knockdown of DDX46 in osteosarcoma cells.
- Evaluated the effect of DDX46 knockdown on cell proliferation, migration, and invasion.
- Conducted in vivo tumor growth assays.
- Analyzed the phosphorylation levels of PI3K and Akt signaling pathway components.
Main Results:
- DDX46 mRNA and protein levels were significantly upregulated in osteosarcoma.
- DDX46 knockdown inhibited osteosarcoma cell proliferation, migration, and invasion in vitro.
- Inhibition of DDX46 suppressed tumor growth in vivo.
- DDX46 knockdown led to decreased phosphorylation of PI3K and Akt.
Conclusions:
- DDX46 is a key driver of osteosarcoma growth and metastasis.
- Targeting DDX46 can impede osteosarcoma progression.
- DDX46 represents a promising therapeutic target for osteosarcoma treatment.
More Related Videos
Related Concept Videos
Inhibition of Cdk Activity
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

